Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia

References

• Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood 2015; 125:1083-90; PMID:25564399; http://dx.doi.org/10.1182/blood-2014-08-550483
   PubMed Web of Science ®Google Scholar
• Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C, Pession A, Kabisch H, Uderzo C, Bonfim CS, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005; 105:410-9; PMID:15353481; http://dx.doi.org/10.1182/blood-2004-05-1944
   PubMed Web of Science ®Google Scholar
• Boultwood J, Wainscoat JS. Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 2007; 138:3-11; PMID:17489980; http://dx.doi.org/10.1111/j.1365-2141.2007.06604.x
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E, Fernandez H, Tallman MS, Greally JM, Carraway H, et al. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 2009; 114:3448-58; PMID:19652201; http://dx.doi.org/10.1182/blood-2009-01-200519
   PubMed Web of Science ®Google Scholar
• Hasegawa D, Manabe A, Kubota T, Kawasaki H, Hirose I, Ohtsuka Y, Tsuruta T, Ebihara Y, Goto Y, Zhao XY, et al. Methylation status of the p15 and p16 genes in paediatric myelodysplastic syndrome and juvenile myelomonocytic leukaemia. Br J Haematol 2005; 128:805-12; PMID:15755284; http://dx.doi.org/10.1111/j.1365-2141.2005.05392.x
   PubMed Web of Science ®Google Scholar
• Johan MF, Bowen DT, Frew ME, Goodeve AC, Reilly JT. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. Br J Haematol 2005; 129:60-5; PMID:15801956; http://dx.doi.org/10.1111/j.1365-2141.2005.05412.x
   PubMed Web of Science ®Google Scholar
• Olk-Batz C, Poetsch AR, Nollke P, Claus R, Zucknick M, Sandrock I, Witte T, Strahm B, Hasle H, Zecca M, et al. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood 2011; 117:4871-80; PMID:21406719; http://dx.doi.org/10.1182/blood-2010-08-298968
   PubMed Web of Science ®Google Scholar
• Poetsch AR, Lipka DB, Witte T, Claus R, Nollke P, Zucknick M, Olk-Batz C, Fluhr S, Dworzak M, De Moerloose B, et al. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics 2014; 9:1252-60; PMID:25147919; http://dx.doi.org/10.4161/epi.29941
   PubMed Web of Science ®Google Scholar
• Gazin C, Wajapeyee N, Gobeil S, Virbasius CM, Green MR. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 2007; 449:1073-7; PMID:17960246; http://dx.doi.org/10.1038/nature06251
   PubMed Web of Science ®Google Scholar
• Ordway JM, Williams K, Curran T. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 2004; 23:3737-48; PMID:14990994; http://dx.doi.org/10.1038/sj.onc.1207483
   PubMed Web of Science ®Google Scholar
• Mohammad HP, Baylin SB. Linking cell signaling and the epigenetic machinery. Nat Biotechnol 2010; 28:1033-8; PMID:20944593; http://dx.doi.org/10.1038/nbt1010-1033
   PubMed Web of Science ®Google Scholar
• Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Br J Haematol 1992; 80:40-8; PMID:1311195; http://dx.doi.org/10.1111/j.1365-2141.1992.tb06398.x
   PubMed Web of Science ®Google Scholar
• Kalaitzidis D, Gilliland DG. Going with the flow: JAK-STAT signaling in JMML. Cancer Cell 2008; 14:279-80; PMID:18835028; http://dx.doi.org/10.1016/j.ccr.2008.09.006
   PubMed Web of Science ®Google Scholar
• Flotho C, Kratz C, Niemeyer CM. Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets 2007; 8:715-25; PMID:17584027; http://dx.doi.org/10.2174/138945007780830773
   PubMed Web of Science ®Google Scholar
• Flotho C, Valcamonica S, Mach-Pascual S, Schmahl G, Corral L, Ritterbach J, Hasle H, Arico M, Biondi A, Niemeyer CM. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999; 13:32-7; PMID:10049057; http://dx.doi.org/10.1038/sj.leu.2401240
   PubMed Web of Science ®Google Scholar
• Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34:148-50; PMID:12717436; http://dx.doi.org/10.1038/ng1156
   PubMed Web of Science ®Google Scholar
• Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet 2010; 42:794-800; PMID:20694012; http://dx.doi.org/10.1038/ng.641
   PubMed Web of Science ®Google Scholar
• Loh ML, Sakai DS, Flotho C, Kang M, Fliegauf M, Archambeault S, Mullighan CG, Chen L, Bergstraesser E, Bueso-Ramos CE, et al. Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood 2009; 114:1859-63; PMID:19571318; http://dx.doi.org/10.1182/blood-2009-01-198416
   PubMed Web of Science ®Google Scholar
• Su B, Bu Y, Engelberg D, Gelman IH. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem 2010; 285:4578-86; PMID:20018890; http://dx.doi.org/10.1074/jbc.M109.073494
   PubMed Web of Science ®Google Scholar
• Flotho C, Paulun A, Batz C, Niemeyer CM. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 2007; 138:644-50; PMID:17686059; http://dx.doi.org/10.1111/j.1365-2141.2007.06709.x
   PubMed Web of Science ®Google Scholar
• Gelman IH. Emerging Roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis. Genes Cancer 2010; 1:1147-56; PMID:21779438; http://dx.doi.org/10.1177/1947601910392984
   PubMedGoogle Scholar
• Lin X, Nelson P, Gelman IH. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)–>S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol 2000; 20:7259-72; PMID:10982843; http://dx.doi.org/10.1128/MCB.20.19.7259-7272.2000
   PubMed Web of Science ®Google Scholar
• Nelson PJ, Gelman IH. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response. Mol Cell Biochem 1997; 175:233-41; PMID:9350056; http://dx.doi.org/10.1023/A:1006836003758
   PubMed Web of Science ®Google Scholar
• Coats SR, Covington JW, Su M, Pabon-Pena LM, Eren M, Hao Q, Vaughan DE. SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression. J Mol Cell Cardiol 2000; 32:2207-19; PMID:11112996; http://dx.doi.org/10.1006/jmcc.2000.1246
   PubMed Web of Science ®Google Scholar
• Streb JW, Kitchen CM, Gelman IH, Miano JM. Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J Biol Chem 2004; 279:56014-23; PMID:15496411; http://dx.doi.org/10.1074/jbc.M408828200
   PubMed Web of Science ®Google Scholar
• Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, Weichenhan D, Lier A, von Paleske L, Renders S, et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA Methylome analysis. Cell Stem Cell 2014; 15:507-22; PMID:25158935; http://dx.doi.org/10.1016/j.stem.2014.07.005
   PubMed Web of Science ®Google Scholar
• Lipka DB, Wang Q, Cabezas-Wallscheid N, Klimmeck D, Weichenhan D, Herrmann C, Lier A, Brocks D, von Paleske L, Renders S, et al. Identification of DNA methylation changes at cis-regulatory elements during early steps of HSC differentiation using tagmentation-based whole genome bisulfite sequencing. Cell Cycle 2014; 13:3476-87; PMID:25483069; http://dx.doi.org/10.4161/15384101.2014.973334
   PubMed Web of Science ®Google Scholar
• Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, et al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 2010; 52:2023-33; PMID:20979053; http://dx.doi.org/10.1002/hep.23939
   PubMed Web of Science ®Google Scholar
• Choi MC, Jong HS, Kim TY, Song SH, Lee DS, Lee JW, Kim NK, Bang YJ. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 2004; 23:7095-103; PMID:15258566; http://dx.doi.org/10.1038/sj.onc.1207932
   PubMed Web of Science ®Google Scholar
• Mori Y, Cai K, Cheng Y, Wang S, Paun B, Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, et al. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterol 2006; 131:797-808; PMID:16952549; http://dx.doi.org/10.1053/j.gastro.2006.06.006
   PubMed Web of Science ®Google Scholar
• Ziller MJ, Gu H, Muller F, Donaghey J, Tsai LT, Kohlbacher O, De Jager PL, Rosen ED, Bennett DA, Bernstein BE, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013; 500:477-81; PMID:23925113; http://dx.doi.org/10.1038/nature12433
   PubMed Web of Science ®Google Scholar
• Camus A, Mesbah K, Rallu M, Babinet C, Barra J. Gene trap insertion reveals two open reading frames in the mouse SSeCKS gene: the form predominantly detected in the nervous system is suppressed by the insertion while the other, specific of the testis, remains expressed. Mech Dev 2001; 105:79-91; PMID:11429284; http://dx.doi.org/10.1016/S0925-4773(01)00384-7
   PubMed Web of Science ®Google Scholar
• Morgan MA, Dolp O, Reuter CW. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling. Blood 2001; 97:1823-34; PMID:11238126; http://dx.doi.org/10.1182/blood.V97.6.1823
   PubMed Web of Science ®Google Scholar
• Turtoi A, Mottet D, Matheus N, Dumont B, Peixoto P, Hennequiere V, Deroanne C, Colige A, De Pauw E, Bellahcene A, et al. The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis 2012; 15:543-54; PMID:22584896; http://dx.doi.org/10.1007/s10456-012-9279-8
   PubMed Web of Science ®Google Scholar
• Furlan I, Batz C, Flotho C, Mohr B, Lubbert M, Suttorp M, Niemeyer CM. Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood 2009; 113:2867-8; PMID:19299654; http://dx.doi.org/10.1182/blood-2008-12-195693
   PubMed Web of Science ®Google Scholar
• Niemeyer CM, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 1997; 89:3534-43; PMID:9160658
   PubMed Web of Science ®Google Scholar
• Klug M, Rehli M. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 2006; 1:127-30; PMID:17965610; http://dx.doi.org/10.4161/epi.1.3.3327
   PubMed Web of Science ®Google Scholar
• Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A 2005; 102:15785-90; PMID:16243968; http://dx.doi.org/10.1073/pnas.0507816102
   PubMed Web of Science ®Google Scholar
• Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Bühler A, Oakes CC, Larson RA, et al. Quantitative DNA Methylation Analysis Identifies a Single CpG Dinucleotide Important for ZAP-70 Expression and Predictive of Prognosis in Chronic Lymphocytic Leukemia. J Clin Oncol 2012; 30:2483-91; PMID:22564988; http://dx.doi.org/10.1200/JCO.2011.39.3090
   PubMed Web of Science ®Google Scholar